COST-EFFECTIVENESS OF QUETIAPINE EXTENDED RELEASE VERSUS OTHER ATYPICAL ANTIPSYCHOTICS IN ACUTE BIPOLAR DEPRESSION

被引：0
|
作者：
Meier, G. [1 ]
Edwards, S. J. [1 ]
von Maltzahn, R. [1 ]
机构：
[1] AstraZeneca UK Ltd, Luton, Beds, England
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)74768-9
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A360 / A360
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF QUETIAPINE EXTENDED RELEASE VERSUS PAROXETINE AND LITHIUM IN ACUTE BIPOLAR DEPRESSION
    Meier, G.
    von Maltzahn, R.
    Parkinson, B. T.
    VALUE IN HEALTH, 2009, 12 (07) : A359 - A360
  • [2] Cost-effectiveness of atypical antipsychotics in acute bipolar mania
    McGarry, LJ
    Bird, A
    Thompson, D
    Wang, P
    Martin, SC
    Weinstein, MC
    VALUE IN HEALTH, 2003, 6 (03) : 352 - 352
  • [3] Cost-effectiveness of lurasidone vs quetiapine extended-release (XR) in patients with bipolar depression
    Rajagopalan, Krithika
    Meyer, Kellie
    O'Day, Ken
    Denno, Melissa
    Loebel, Antony
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (10) : 821 - 827
  • [4] Bipolar depression: quetiapine extended release effectiveness
    Porcelli, S.
    Savoia, E. M.
    Bonafede, R.
    Moretti, F.
    Carchia, G.
    Belvedere, M.
    De Ronchi, D.
    Serretti, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S432 - S432
  • [5] Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression
    Suppes, Trisha
    Datto, Catherine
    Minkwitz, Margaret
    Nordenhem, Arvid
    Walker, Chris
    Darko, Denis
    JOURNAL OF AFFECTIVE DISORDERS, 2010, 121 (1-2) : 106 - 115
  • [6] COST-EFFECTIVENESS ANALYSIS OF LURASIDONE VERSUS QUETIAPINE XR IN PATIENTS WITH BIPOLAR DEPRESSION
    O'Day, K.
    Hassan, M.
    Rajagopalan, K.
    Meyer, K.
    Denno, M. S.
    Loebel, A.
    VALUE IN HEALTH, 2014, 17 (03) : A216 - A216
  • [7] Quetiapine versus other atypical antipsychotics for schizophrenia
    Komossa, Katja
    Rummel-Kluge, Christine
    Schmid, Franziska
    Hunger, Heike
    Schwarz, Sandra
    Srisurapanont, Manit
    Kissling, Werner
    Leucht, Stefan
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (01):
  • [8] Quetiapine versus other atypical antipsychotics for schizophrenia
    Asmal, Laila
    Flegar, Srnka J.
    Wang, Jikun
    Rummel-Kluge, Christine
    Komossa, Katja
    Leucht, Stefan
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (11):
  • [9] Cost-effectiveness of atypical antipsychotics in the treatment of acute mania
    Meletiche, DM
    Meyer, K
    Franklin, M
    Poston, S
    Grogg, A
    VALUE IN HEALTH, 2006, 9 (03) : A66 - A67
  • [10] COST-EFFECTIVENESS OF ASENAPINE VERSUS ATYPICAL ANTIPSYCHOTICS USED IN TURKEY IN THE TREATMENT OF BIPOLAR I DISORDER
    Pala, M.
    Ozdemir, S.
    Ozdemir, O.
    VALUE IN HEALTH, 2013, 16 (07) : A548 - A548
12345